BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:W. Europe Standard Time
BEGIN:STANDARD
DTSTART:20251002T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=3;BYMINUTE=0;BYMONTH=10
TZNAME:W. Europe Standard Time
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:W. Europe Daylight Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:\n\n\n\n&nbsp\;\nDott. Peter Grasso\, Head of Clinical Support 
 at MED-EL\n\n\n&nbsp\;\n\n\n\n\n&nbsp\;\n\n\n\n\nThis webinar will delve i
 nto cleft palate and how this is often correlated to hearing loss. The ADH
 EAR will be discussed\, as it may represent an important alleviation for t
 his subgroup of users.
DTEND:20220627T123000Z
DTSTAMP:20260710T080440Z
DTSTART:20220627T120000Z
LOCATION:
SEQUENCE:0
SUMMARY:When Are Patients With Cleft Palate Potential Candidates For ADHEAR
 ?
UID:RFCALITEM639192674805766772
X-ALT-DESC;FMTTYPE=text/html:<div class="col-md-12 col-sm-12">\n<div class=
 "col-xs-12 col-sm-4 col-md-4 col-lg-4" style="padding: 0\;">\n<div>\n<img 
 src="https://sfc01.cdn.medel.com/images/librariesprovider2/events/eventson
 line/speaker-images/peter-grasso.png?auto=format&amp\;sfvrsn=256cdb43_0&am
 p\;sf_site_temp=true&amp\;sf_site=00000000-0000-0000-0000-000000000000" al
 t="Peter Grasso" title="Peter Grasso" data-displaymode="Original" />\n&nbs
 p\;</div>\n<div>Dott. Peter Grasso\, Head of Clinical Support at MED-EL</d
 iv>\n</div>\n<div class="col-xs-12 col-sm-4 col-md-4 col-lg-4 hidden-xs" s
 tyle="padding: 0\;">\n<div>&nbsp\;</div>\n<div>\n</div>\n</div>\n<div clas
 s="col-xs-12 col-sm-4 col-md-4 col-lg-4 hidden-xs" style="padding: 0\;">\n
 <div>&nbsp\;</div>\n<div>\n</div>\n</div>\n</div>\n<div class="col-lg-12 c
 ol-md-12 col-sm-12 col-xs-12 margin-bottom-2x margin-top-2x" style="paddin
 g: 0\;">This webinar will delve into cleft palate and how this is often co
 rrelated to hearing loss. The ADHEAR will be discussed\, as it may represe
 nt an important alleviation for this subgroup of users.</div>
END:VEVENT
END:VCALENDAR